Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice
- PMID: 20623580
- PMCID: PMC3700412
- DOI: 10.1002/hep.23721
VSports - Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice
Abstract
Cholesterol 7alpha-hydroxylase (CYP7A1) is the rate-limiting enzyme in the bile acid biosynthetic pathway that converts cholesterol into bile acids in the liver. Recent studies have shown that bile acids may play an important role in maintaining lipid, glucose, and energy homeostasis. However, the role of CYP7A1 in the development of obesity and diabetes is currently unclear. In this study, we demonstrated that transgenic mice overexpressing Cyp7a1 in the liver [i. e. , Cyp7a1 transgenic (Cyp7a1-tg) mice] were resistant to high-fat diet (HFD)-induced obesity, fatty liver, and insulin resistance VSports手机版. Cyp7a1-tg mice showed increased hepatic cholesterol catabolism and an increased bile acid pool. Cyp7a1-tg mice had increased secretion of hepatic very low density lipoprotein but maintained plasma triglyceride homeostasis. Gene expression analysis showed that the hepatic messenger RNA expression levels of several critical lipogenic and gluconeogenic genes were significantly decreased in HFD-fed Cyp7a1-tg mice. HFD-fed Cyp7a1-tg mice had increased whole body energy expenditure and induction of fatty acid oxidation genes in the brown adipose tissue. .
Conclusion: This study shows that Cyp7a1 plays a critical role in maintaining whole body lipid, glucose, and energy homeostasis V体育安卓版. The induction of CYP7A1 expression with the expansion of the hydrophobic bile acid pool may be a potential therapeutic strategy for treating metabolic disorders such as fatty liver diseases, obesity, and diabetes in humans. .
"V体育官网入口" Conflict of interest statement
Potential conflict of interest: Nothing to report.
Figures







References
-
- Schwartz SL. Diabetes and dyslipidaemia. Diabetes Obes Metab. 2006;8:355–364. - V体育ios版 - PubMed
-
- Biddinger SB, Kahn CR. From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol. 2006;68:123–158. - PubMed
-
- Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. HEPATOLOGY. 2006;43:S99–S112. - PubMed
-
- Miyake JH, Duong-Polk XT, Taylor JM, Du EZ, Castellani LW, Lusis AJ, et al. Transgenic expression of cholesterol-7a-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arterioscler Thromb Vasc Biol. 2002;22:121–126. - PubMed
"V体育安卓版" Publication types
"VSports" MeSH terms
- V体育2025版 - Actions
- Actions (V体育官网入口)
- Actions (V体育平台登录)
- "VSports最新版本" Actions
Substances
- V体育安卓版 - Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
"V体育官网入口" Molecular Biology Databases
Miscellaneous